Edition:
United States

People: Novo Nordisk A/S (NVO)

NVO on New York Consolidated

33.93USD
2 Dec 2016
Change (% chg)

$0.38 (+1.13%)
Prev Close
$33.55
Open
$33.87
Day's High
$34.00
Day's Low
$33.67
Volume
3,790,173
Avg. Vol
4,001,720
52-wk High
$59.00
52-wk Low
$30.89

Rebien Soerensen, Lars 

Mr. Lars Rebien Soerensen no longer serves as Chief Executive Officer (CEO) and President at Novo Nordisk A/S effective as of by the end of 2016 (December 31, 2016). He has been CEO since November 2000 and he has served as President of the Company since April 2015. He also served as President of the Company from November 2000 until January 30, 2014. He joined the Company's Enzymes Marketing in 1982. Over the years, he has been stationed in several countries, including the Middle East and the United States. He was appointed Member of Corporate Management in May 1994, and was given responsibility for Health Care within Corporate Management in December 1994. He is Vice Chairman of the Boards of Directors of Carlsberg A/S. He received the French award Chevalier de l'Ordre National de la Legion d'Honneur in 2005. Since October 2007, he has been Adjunct Professor at the Faculty of Life Sciences of Koebenhavns Universitet (the University of Copenhagen). He holds a Master of Science degree in Forestry from Koebenhavns Universitet from 1981 and a Bachelor of Science degree in International Economics from Copenhagen Business School from 1983.

Basic Compensation

Total Annual Compensation, DKK 26,500,000
Restricted Stock Awards, DKK --
Long-Term Incentive Plans, DKK --
All Other, DKK 300,000
Fiscal Year Total, DKK 26,800,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --